Find policies, billing codes, payers, states, and providers
CPT 40490: Incisional Biopsy of Lip, Diagnostic Tissue Sampling
CPT code 40490 denotes an incisional biopsy of the lip performed to obtain a tissue sample from a lesion for diagnostic evaluation. As a commonly used minor surgical procedure, it is important for confirming benign versus malignant pathology and guiding subsequent treatment decisions. Nationally, accurate coding and documentation for this procedure affect claims processing, clinical records, and downstream care pathways.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of clinical context for the procedure, typical sites of service, common presenting ICD-10 diagnoses associated with lip lesions, and adjacent procedural coding used in practice (for example, related excisional procedures). The report outlines typical billing considerations, common modifiers used in practice, and associated provider taxonomies that commonly submit this service.
This summary provides clinicians, billing staff, and policy analysts with a clear snapshot of what CPT code 40490 represents, why it matters for diagnostic workflows and revenue cycle operations, and where it sits relative to neighboring lip procedures. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 40490 policy alerts
Get alerted when payer policies referencing 40490 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 40490 describes a biopsy of the lip performed by incising the lip and obtaining a tissue sample of a lesion for diagnostic purposes. This procedure is a minor surgical diagnostic service focused on obtaining tissue for histopathologic examination.
Service Type: Diagnostic surgical procedure (lip biopsy)
Typical Site of Service: Outpatient clinic or ambulatory surgical setting, including dermatology, oral surgery, or otolaryngology clinics
National Reimbursement Benchmarks
Nationally, Medicare’s mean allowed amount of $124.40 sits well below BUCA’s commercial average of $374.00, indicating a substantial commercial premium over the Medicare baseline for CPT 40490. That gap of $249.60 highlights how commercial networks, represented here by BUCA, reimburse notably more on average than the Medicare program.
Rate dispersion varies by payer: Blue Cross Blue Shield exhibits the widest interquartile spread with P75–P25 = $171.50 ($629.20 - $447.70), followed by UnitedHealth Group at $119.80 ($233.60 - $113.80). Aetna’s IQR is $82.00 ($123.10 - $41.00), Cigna’s is $105.50 ($205.90 - $97.40), and BUCA’s is $148.00 ($439.90 - $291.90). Medicare’s IQR is narrow at $13.00 ($129 - $116), indicating the tightest midrange among payers.